Tesla
TSLA
Broadcom
AVGO
Netflix
NFLX
Amazon
AMZN
Cisco
CSCO
US Stock MarketDetailed Quotes
ENSC Ensysce Biosciences
- 9.9800
- +1.7200+20.82%
Close Dec 24 13:00 ET
- 10.1500
- +0.1700+1.70%
Post 17:01 ET
13.02MMarket Cap-0.34P/E (TTM)
10.9600High8.0200Low230.87KVolume8.4900Open8.2600Pre Close2.26MTurnover23.92%Turnover RatioLossP/E (Static)1.30MShares30.900052wk High1.88P/B9.63MFloat Cap2.118052wk Low--Dividend TTM965.13KShs Float86364.0000Historical High--Div YieldTTM35.59%Amplitude2.1150Historical Low9.7820Avg Price1Lot Size
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Ensysce Biosciences Stock Forum
we are going up up and up
SIRI and OXY are attractively valued for minimal returns.
$Sirius XM (SIRI.US)$ holds the most long term value as it has the best chance of obtaining higher percentage gains.
You should adjust your investment strategy as often as possible in order to achieve maximum gains.
These are short term investments for maximum gains:
$Reborn Coffee (REBN.US)$ Has resistance at 2.04 and th...
📊⚡️📊
Dec. 23, 2024 8:12 AM
Ensysce Biosciences Regains Full Compliance with Nasdaq
Monday, 23rd December at 8:00 am
SAN DIEGO, CALIFORNIA / ACCESSWIRE / December 23, 2024 / Ensysce Biosciences, Inc. (NASDAQ: ENSC) ("Ensysce" or "Company"), a clinical-stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the potential for opioid abuse and overdose, today announced that on December 20, 2024, it received notice from The Nasdaq Stock Market LLC ("...
$Checkpoint Therapeutics (CKPT.US)$ $Fortress Biotech (FBIO.US)$ FDA approval of drug for metastatic cutaneous squamous cell carcinoma. This drug is the first and only progr...
No comment yet